Massey Stewart R

Director Massey Stewart R sold 44,000 INOD shares (63.5% of holdings) for $2.8M at $63.66 blended avg on 2025-02-26

Massey Stewart R executed 2 separate sales totaling 44,000 shares for $2,801,024.65, reducing his holdings by 63.5% from 69.3K to 25.3K shares. The transaction occurred at a blended average price of $63.66, coinciding with the stock's 52-week high of $64.17 (+93.3% in 30 days, +67.4% in 90 days). Reviewing his same-ticker history at INOD, 3 prior sales on 2024-11-13 showed mixed timing outcomes (90-day returns of +5.9%, +4.0%, and -0.6%), with only 1 of 3 well-timed at the 90-day mark. His cross-ticker track record shows 3 prior sells with a 90-day well-timed rate of 33.33%, though most recent 90-day returns averaged +3.1%. The timing of this substantial reduction at an elevated price level, following the stock's sharp multi-month appreciation, presents a factual observation for investor scrutiny given the magnitude of the position reduction.

Director Massey Stewart R sold 50,000 shares (66.4% of holdings) for $2.0M at $40.55 avg on 2024-11-13.

Director Massey Stewart R executed 3 separate sales totaling 50,000 shares for $2,027,636.30, reducing his position from 75.3K to 25.3K shares—a 66.4% reduction in holdings. The sales occurred at a blended average price of $40.55, which is 3.5% above the current price of $39.16 but well below the 52-week high of $45.99. The stock has surged 131.4% in the past 30 days and 129.5% in the past 90 days from a 52-week low of $5.69, placing this sale within a period of substantial recovery. While the company reported positive quarterly net income of $17.4M and 9.8% annual revenue growth, it was unprofitable on a full-year basis, and the elevated 69.93 P/E suggests investor expectations may be pricing in near-term performance gains. The magnitude and sequencing of this position reduction warrants attention regarding the insider's forward-looking view of valuation at these recovered price levels.